Evidence map›Paper›PMID 40140175›Full record

ArticleActa parasitologica2025

Are There Atypical Leishmania Species Responsible for the Kala-Azar Persistence in Northeast Iran?

Reza Shafiei, Amir Azimian, Mahdi Mohebali, Zahra Badiei, Nima Firouzeh, Saber Raeghi

Abstract read
PubMed Publisher
In one paragraph

Article in Acta parasitologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Reza ShafieiVector-borne Diseases Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Amir AzimianDepartment of Pathology and Laboratory Sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Mahdi MohebaliCenter for Research of Endemic Parasites of Iran, Tehran University of Medical Sciences, Tehran, Iran.
Zahra BadieiDepartment of Pediatrics, School of Medicine, Sheikh Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Nima Firouzeh *Vector-borne Diseases Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran. Nimafirouzeh4@gmail.com.
Saber Raeghi *Department of Parasitology & Mycology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran. Saberraeghi@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

porpuseHuman visceral leishmaniasis (HVL) is a severe form of leishmaniasis caused by protozoan parasites of the genus Leishmania.

methodsFrom 2013 to 2022, this study, molecular diagnosis was conducted on 50 pediatric bone marrow aspiration samples from northeast Iran, all of which had previously been confirmed to have visceral leishmaniasis. The ITS-rDNA gene and phylogenetic analysis were performed.

resultsThe results revealed that 49 samples tested positive for L. infantum species, whereas 1 sample was identified as L. major. All three L. infantum isolates showed similar haplotypes, whereas the L. major isolate exhibited nucleotide differences in the sequence analyzed.

conclusionIt could be concluded that visceral manifestations of cutaneous leishmaniasis in children living in endemic areas should be considered a contributing factor to the development of HVL. The present study provides a relatively comprehensive snapshot of unusual leishmania species status that could be responsible for HVL development.

Indexed as

LeishmaniaLeishmania infantumLeishmania majorLeishmaniasis, VisceralChildChild, PreschoolDNA, ProtozoanDNA, Ribosomal SpacerFemaleHumansInfantIranMalePhylogenyDNA, ProtozoanDNA, Ribosomal SpacerIranITS-rDNAL. MajorVisceral LeishmaniasisViscerotropic

Identifiers

PMID40140175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.